You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series

Article info

Article menu

Download PDFPDF

XML
Case Report
In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series

Authors

  • Melody J. Xu Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer CenterUniversity of California San Francisco 1600 Divisadero Street, Suite H-1031 94115 San Francisco CA USA PubMed articlesGoogle scholar articles
  • Susan Wu Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer CenterUniversity of California San Francisco 1600 Divisadero Street, Suite H-1031 94115 San Francisco CA USA PubMed articlesGoogle scholar articles
  • Adil I. Daud Department of MedicineUniversity of California San Francisco San Francisco CA USA PubMed articlesGoogle scholar articles
  • Siegrid S. Yu Department of DermatologyUniversity of California San Francisco San Francisco CA USA PubMed articlesGoogle scholar articles
  • Sue S. Yom Department of Radiation Oncology, Helen Diller Family Comprehensive Cancer CenterUniversity of California San Francisco 1600 Divisadero Street, Suite H-1031 94115 San Francisco CA USA PubMed articlesGoogle scholar articles
  1. ↵a Melody.Xu{at}ucsf.edu
  2. ↵b Susan.Wu{at}ucsf.edu
  3. ↵c Adil.Daud{at}ucsf.edu
  4. ↵d Siegrid.Yu{at}ucsf.edu
  5. ↵e (415) 353-7175 Sue.Yom{at}ucsf.edu
View Full Text

Citation

Xu MJ, Wu S, Daud AI, et al
In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series
Journal for ImmunoTherapy of Cancer 2018;6:43. doi: 10.1186/s40425-018-0352-8

Publication history

  • Received March 4, 2018
  • Accepted May 7, 2018
  • First published May 30, 2018.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.